Nanae Tsuruoka

Nabeshima, 8498501, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team.

Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team.

Journal: Journal of gastroenterology

Published: January 23, 2026

Efficacy and Recovery of Remimazolam Versus Midazolam in Sedated Colonoscopy: A Multicenter Randomized Controlled Trial in Japan.

Efficacy and Recovery of Remimazolam Versus Midazolam in Sedated Colonoscopy: A Multicenter Randomized Controlled Trial in Japan.

Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society

Published: September 25, 2025

Efficacy and recovery of remimazolam versus midazolam in sedated upper gastrointestinal endoscopy: a multicenter randomized controlled trial in Japan (RECOVER Study).

Efficacy and recovery of remimazolam versus midazolam in sedated upper gastrointestinal endoscopy: a multicenter randomized controlled trial in Japan (RECOVER Study).

Journal: Journal of gastroenterology

Published: September 16, 2025

Involvement of Periostin in Intestinal Fibrosis Associated With Crohn's Disease.

Involvement of Periostin in Intestinal Fibrosis Associated With Crohn's Disease.

Journal: Journal of gastroenterology and hepatology

Published: September 11, 2025

The Usefulness of Over-the-Scope Clips for Managing Gastrointestinal Complications of Endoscopic or Surgical Procedures: The SAGA-OTSC Registry Study.

The Usefulness of Over-the-Scope Clips for Managing Gastrointestinal Complications of Endoscopic or Surgical Procedures: The SAGA-OTSC Registry Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: June 24, 2025

Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan.

Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan.

Journal: Journal of gastroenterology

Published: June 23, 2025

Induction Efficacy and Safety of Upadacitinib for Active Crohn's Disease in Japanese Patients: A Multicenter Retrospective Study.

Induction Efficacy and Safety of Upadacitinib for Active Crohn's Disease in Japanese Patients: A Multicenter Retrospective Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: May 10, 2025

Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn's Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team.

Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn's Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team.

Journal: Inflammatory bowel diseases

Published: December 17, 2024

Serum Periostin is Able to Stratify Type 2-Dominant Ulcerative Colitis.

Serum Periostin is Able to Stratify Type 2-Dominant Ulcerative Colitis.

Journal: Inflammatory bowel diseases

Published: October 03, 2024

Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn's disease.

Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn's disease.

Journal: Journal of gastroenterology

Published: August 28, 2024

Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report.

Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report.

Journal: Intestinal research

Published: January 22, 2024

Predictive factors of the clinical efficacy of ustekinumab in patients with refractory Crohn's disease: tertiary centers experience in Japan.

Predictive factors of the clinical efficacy of ustekinumab in patients with refractory Crohn's disease: tertiary centers experience in Japan.

Journal: International journal of colorectal disease

Published: February 23, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026